Fox Run Management L.L.C. Increases Stake in Quanterix Co. (NASDAQ:QTRX)

Fox Run Management L.L.C. increased its position in shares of Quanterix Co. (NASDAQ:QTRX) by 258.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 43,784 shares of the company’s stock after buying an additional 31,577 shares during the period. Fox Run Management L.L.C. owned about 0.11% of Quanterix worth $465,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in QTRX. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Quanterix in the 3rd quarter valued at approximately $500,000. Intech Investment Management LLC purchased a new position in Quanterix in the third quarter valued at $170,000. Algert Global LLC raised its stake in Quanterix by 75.9% in the third quarter. Algert Global LLC now owns 137,833 shares of the company’s stock valued at $1,786,000 after buying an additional 59,496 shares in the last quarter. FMR LLC lifted its holdings in Quanterix by 112.6% during the 3rd quarter. FMR LLC now owns 30,242 shares of the company’s stock worth $392,000 after buying an additional 16,020 shares during the last quarter. Finally, Portolan Capital Management LLC boosted its position in shares of Quanterix by 31.4% during the 3rd quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock worth $32,668,000 after acquiring an additional 602,656 shares in the last quarter. Institutional investors and hedge funds own 86.48% of the company’s stock.

Analyst Ratings Changes

QTRX has been the subject of several recent analyst reports. Scotiabank decreased their target price on Quanterix from $28.00 to $18.00 and set a “sector outperform” rating for the company in a research note on Tuesday. Canaccord Genuity Group dropped their target price on shares of Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Tuesday, March 18th.

Quanterix Stock Down 2.4 %

QTRX opened at $7.02 on Wednesday. Quanterix Co. has a 52 week low of $6.30 and a 52 week high of $23.94. The business’s 50 day moving average is $8.12 and its two-hundred day moving average is $10.75. The firm has a market cap of $272.21 million, a price-to-earnings ratio of -6.62 and a beta of 1.33.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, March 17th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03). The business had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.93 million. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. Equities analysts expect that Quanterix Co. will post -0.98 EPS for the current fiscal year.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.